APDN - Applied DNA Sof marja

Applied DNA Sciences (APDN) grafik logotipi

Realizatsiya marjasi koeffitsiyenti Applied DNA Sciences (APDN) kompaniyasining joriy daromadliligini ko'rsatadi, bunda -2047.40 ko'rsatkichi parametr holatini belgilaydi. Biznes barqarorligi o'rtacha pul oqimlari sharoitida DNK diagnostikasi va brend himoyasiga tayanadi. Kompetent boshqaruv biomateriallarni muvaffaqiyatli sintez qilmoqda va keng ko'lamli tijorat muvaffaqiyatiga intilmoqda. Moliyaviy muvozanat aksiyalar emissiyasi orqali ta'minlanadi, bu esa mahsulot autentifikatsiyasiga bo'lgan talabning kamayishi bilan bog'liq xatarlarni yumshatadi.

Applied DNA Corp (APDN) - Sof foyda bo'yicha sotuv rentabelligi 04.07.2022dan 07.10.2025gacha

Applied DNA Sciences kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:Applied DNA Sciences Inc - APDN
Applied DNA yetakchi tovari

Sotuv marjasi barcha xarajatlar chegirib tashlanganidan keyin, har bir rubl daromadidagi sof foyda ulushini o'lchaydi. Ushbu metrika real samaradorlikni nominal daromad o'sishidan ajratgan holda, yashirin xarajatlar inflyatsiyasini aniqlash imkonini beradi. Sof marjini tahlil qilish operatsion xarajatlarni boshqarish sifatini ob'ektiv baholashga yordam beradi. Applied DNA Sciences (APDN) uchun bioxavfsizlik sohasidagi kuchli narx belgilash imkoniyati barqaror daromadlilikni ta'minlashi kerak. LinearDNA platformasining noyobligi talabni elastik emas qiladi, bu esa bevosita premium marjaga aylanadi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|NAUT: Sotuvning sof rentabelligi|MGX: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Precision BioSciences|GBIO (generationbio.com) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IMNN (Imunon, Inc.)|Sotuvning sof marjinal rentabelligi PHIO|MBIO - Sof marja|Sotuvning sof marjinal rentabelligi RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Sof marja|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX